Dexter Robot Sweeps the Four Biggest Outpatient Surgeries

Distalmotion's Dexter system wins FDA clearance for ventral hernia repair, covering the top four outpatient procedures.

15 Aug 2026

Distalmotion has received FDA 510(k) clearance for its Dexter robotic surgery system to perform ventral hernia repair. That completes a set of authorizations now covering the four highest-volume soft tissue procedures done in ambulatory surgery centers nationwide, following earlier clearances for hysterectomy, cholecystectomy, and inguinal hernia repair.

Distalmotion said these four procedures together account for more than three million surgeries a year in the United States. Ventral hernia repair alone makes up over 600,000 operations, more than 75 percent of which already happen outside traditional hospital operating rooms.

The system's open architecture works with visualization equipment a surgical center already owns. Its bedside access design sets it apart from the cart-based or table-integrated approaches that larger competitors build mainly for hospital programs, reflecting a broader 2026 pattern in which regulators evaluate new platforms specifically for outpatient fit rather than assuming hospitals as the default.

For ambulatory centers weighing their first robotics investment, a platform cleared across the highest-volume procedure types removes a real share of the case-mix uncertainty that has slowed adoption outside hospitals. The clearance adds to a wider set of 2026 regulatory actions addressing where robotic and AI-assisted surgery can be deployed.